ReviewJournal of clinical medicine2022

Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review.

Hideaki Yamakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.